News | September 28, 2022
LISSUN raises ~$1 million in pre-Seed round from IvyCap Ventures and others
Funds raised will be used to develop technology and foster healthcare partnerships
Funds raised will be used to develop technology and foster healthcare partnerships
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
Transformation to pure-play Innovative Medicines company nears completion
The committee unanimously decided to confer the Lifetime Achievement Award to Kiran Mazumdar-Shaw for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship
The companies will leverage their respective proprietary technology platforms
The #Heart2HeartChallengeIndia campaign is very simple – you have to climb 60 steps in a minute, make a video of it, share it on your social media, tag 5 people, inviting them to take this challenge to check their heart health
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
The startup plans to provide free technology to dental clinics upon registration.
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
Subscribe To Our Newsletter & Stay Updated
